Jin Yang

Summary

Country: China

Publications

  1. pmc Hepatitis B virus core protein with hot-spot mutations inhibit MxA gene transcription but has no effect on inhibition of virus replication by interferon α
    Yu Zhijian
    Department of Infectious Diseases, The Affiliated Shenzhen Nanshan Hospital of Guangdong Medical College, Shenzhen, China
    Virol J 7:278. 2010
  2. pmc Elective caesarean section versus vaginal delivery for preventing mother to child transmission of hepatitis B virus--a systematic review
    Jin Yang
    Center of Infectious Diseases, National Key Laboratory of Biotherapy for Human Diseases, West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province, PR China
    Virol J 5:100. 2008
  3. pmc Clinical significance of 4 patients with chronic hepatitis B achieving HBsAg clearance by treated with pegylated interferon alpha-2a for less than 1 year: a short report
    Jin Yang
    Center of Infectious Diseases, National Key Laboratory of Biotherapy for Human Diseases, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
    Virol J 6:97. 2009
  4. pmc Interferon for the treatment of genital warts: a systematic review
    Jin Yang
    Department of Infectious Diseases, Nanshan Affiliated Hospital of Guangdong Medical College, Shenzhen 518052, PR China
    BMC Infect Dis 9:156. 2009
  5. doi request reprint Bifidobacterium as an oral delivery carrier of interleukin-12 for the treatment of Coxsackie virus B3-induced myocarditis in the Balb/c mice
    Zhijian Yu
    Department of Infectious Diseases, Shenzhen Nanshan People s Hospital, Guangdong Medical College, Shenzhen, China
    Int Immunopharmacol 12:125-30. 2012
  6. pmc Oral administration of interferon-α2b-transformed Bifidobacterium longum protects BALB/c mice against coxsackievirus B3-induced myocarditis
    Zhijian Yu
    Department of Infectious Diseases, The Affiliated Shenzhen Nanshan Hospital of Guangdong Medical College, No 89 Taoyuan Road, Nanshan District, Shenzhen, China
    Virol J 8:525. 2011
  7. doi request reprint Increased mRNA expression of interferon-induced Mx1 and immunomodulation following oral administration of IFN-alpha2b-transformed B. longum to mice
    Zhijian Yu
    Department of Infectious Diseases, The Affiliated Shenzhen Nanshan Hospital of Guangdong Medical College, No 89 Taoyuan Road, Nanshan District, Shenzhen 518052, China
    Arch Microbiol 192:633-8. 2010
  8. pmc Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis
    Yuan Yuan Zhang
    Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, PR China
    Virol J 6:63. 2009

Collaborators

Detail Information

Publications8

  1. pmc Hepatitis B virus core protein with hot-spot mutations inhibit MxA gene transcription but has no effect on inhibition of virus replication by interferon α
    Yu Zhijian
    Department of Infectious Diseases, The Affiliated Shenzhen Nanshan Hospital of Guangdong Medical College, Shenzhen, China
    Virol J 7:278. 2010
    ..The clinical significance of the inhibitory effect of MxA gene transcription by HBc protein requires further study...
  2. pmc Elective caesarean section versus vaginal delivery for preventing mother to child transmission of hepatitis B virus--a systematic review
    Jin Yang
    Center of Infectious Diseases, National Key Laboratory of Biotherapy for Human Diseases, West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province, PR China
    Virol J 5:100. 2008
    ..The aim of this review is to assess, from randomized control trails (RCTs), the efficacy and safety of ECS versus vaginal delivery in preventing mother-to-child HBV transmission...
  3. pmc Clinical significance of 4 patients with chronic hepatitis B achieving HBsAg clearance by treated with pegylated interferon alpha-2a for less than 1 year: a short report
    Jin Yang
    Center of Infectious Diseases, National Key Laboratory of Biotherapy for Human Diseases, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
    Virol J 6:97. 2009
    ....
  4. pmc Interferon for the treatment of genital warts: a systematic review
    Jin Yang
    Department of Infectious Diseases, Nanshan Affiliated Hospital of Guangdong Medical College, Shenzhen 518052, PR China
    BMC Infect Dis 9:156. 2009
    ..The aim of this review is to assess, from randomized control trials (RCTs), the efficacy and safety of interferon in curing genital warts...
  5. doi request reprint Bifidobacterium as an oral delivery carrier of interleukin-12 for the treatment of Coxsackie virus B3-induced myocarditis in the Balb/c mice
    Zhijian Yu
    Department of Infectious Diseases, Shenzhen Nanshan People s Hospital, Guangdong Medical College, Shenzhen, China
    Int Immunopharmacol 12:125-30. 2012
    ..Oral administration of mIL-12-transformed B. longum may play a therapeutic role in the treatment of CVB3-induced myocarditis in the mice...
  6. pmc Oral administration of interferon-α2b-transformed Bifidobacterium longum protects BALB/c mice against coxsackievirus B3-induced myocarditis
    Zhijian Yu
    Department of Infectious Diseases, The Affiliated Shenzhen Nanshan Hospital of Guangdong Medical College, No 89 Taoyuan Road, Nanshan District, Shenzhen, China
    Virol J 8:525. 2011
    ..Oral administration of the IFN-transformed B. longum, therefore, may play a potential role in the treatment of CVB3-induced myocarditis...
  7. doi request reprint Increased mRNA expression of interferon-induced Mx1 and immunomodulation following oral administration of IFN-alpha2b-transformed B. longum to mice
    Zhijian Yu
    Department of Infectious Diseases, The Affiliated Shenzhen Nanshan Hospital of Guangdong Medical College, No 89 Taoyuan Road, Nanshan District, Shenzhen 518052, China
    Arch Microbiol 192:633-8. 2010
    ..longum expressing IFN-alpha2b might play its roles in the immunomodulation of the mice, and the potential clinical value of this bacterium in the treatment of viral infections needs to be further studied...
  8. pmc Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis
    Yuan Yuan Zhang
    Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, PR China
    Virol J 6:63. 2009
    ..The aim of this study was to compare the effect of lamivudine monotherapy with that of lamivudine and thymosin alpha-1 combination therapy for the treatment of hepatitis B e antigen (HBeAg)-positive hepatitis B patients...